title: Requirements for generic anti-epileptic medicines: a regulatory perspective.
authors: MEB-CBG/Radboud University Medical Centre, 579, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. m.maliepaard@cbg-meb.nl
authors: Marc
authors: M
authors: Maliepaard
authors: Yechiel A
authors: YA
authors: Hekster
authors: Arnoud
authors: A
authors: Kappelle
authors: Eugène P
authors: EP
authors: van Puijenbroek
authors: André J
authors: AJ
authors: Elferink
authors: Jan
authors: J
authors: Welink
authors: Christine C
authors: CC
authors: Gispen-de Wied
authors: Frits J F
authors: FJ
authors: Lekkerkerker
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000592:standards*; D002986:Clinical Trials as Topic / Q000592:standards; D000075202:Contraindications; D057915:Drug Substitution / Q000009:adverse effects / Q000592:standards; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence* / Q000639:trends; D016568:Drugs, Generic / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000592:standards*; D004827:Epilepsy / Q000188:drug therapy* / Q000517:prevention & control; D005062:European Union; D006801:Humans; D010349:Patient Compliance / Q000523:psychology; D013810:Therapeutic Equivalency
chemical_list: D000927:Anticonvulsants; D016568:Drugs, Generic